Skip to main content
Top

Lung

Issue 2/2006

Content (9 Articles)

Oxidant–Antioxidant Balance in Patients with COPD

Ismail Hanta, Ali Kocabas, Necmiye Canacankatan, Sedat Kuleci, Gulsah Seydaoglu

Technetium-99m Hexamethylpropylene Amine Oxime Lung Scintigraphy Findings in Low-Dose Amiodarone Therapy

G. Capa Kaya, T. Ertay, B. Tuna, R. Bekis, C. Tasci, E. Sayit, O. Yılmaz, A. Kargı, H. Durak

Effects of Early Intervention with Inhaled Sodium Cromoglycate in Childhood Asthma

S. Yoshihara, N. Kanno, Y. Yamada, M. Ono, N. Fukuda, M. Numata, T. Abe, O. Arisaka

Relationship Among Pulmonary Function, Bronchial Hyperresponsiveness, and Atopy in Children with Clinically Stable Asthma

Eugene Yang, Woojung Kim, Byoung Chul Kwon, Sung Yeon Choi, Myung Hyun Sohn, Kyu-Earn Kim

TNF-α Promoter Polymorphism in Relation to TNF-α Production and Clinical Status in Cystic Fibrosis

Sabina Schmitt-Grohé, Frank Stüber, Malte Book, Joachim Bargon, Thomas O. Wagner, Christian Naujoks, Ralf Schubert, Michael J. Lentze, Stefan Zielen

Pleurodesis Induced by Talc or Silver Nitrate: Evaluation of Collagen and Elastic Fibers in Pleural Remodeling

Leila Antonangelo, Francisco S. Vargas, Lisete R. Teixeira, Milena M. P. Acencio, Marcelo A. Costa Vaz, Mário Terra Filho, Evaldo Marchi

The Effects of Age on Exhaled Breath Nitric Oxide Levels

Robert R. Haight, Robert L. Gordon, Stuart M. Brooks

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine